Reprogramming of somatic cells achieved by combination of the four transcription factors Oct4, Sox2, Klf4, and c-Myc has very low efficiency. To increase the reprogramming efficiency and better understand the process, we sought to identify factors that mediate reprogramming with higher efficiency. We established an assay to screen nuclear fractions from extracts of pluripotent mouse cells based on Oct4 reactivation. Using proteomics, we identified components of the ATP-dependent BAF chromatinremodeling complex, which significantly increases reprogramming efficiency when used together with the four factors. The reprogrammed cells could transmit to the germline and exhibited pluripotency. Reprogramming remained highly efficient when c-Myc was not present but BAF components were overexpressed. BAF complex components mediate this effect by facilitating enhanced Oct4 binding to target promoters during reprogramming. Thus, somatic cell reprogramming using chromatin-remodeling molecules represents an efficient method of generating reprogrammed cells.
INTRODUCTION
Somatic cell reprogramming using transduction with the transcription factors Oct4, Sox2, Klf4, and c-Myc-i.e., the ''four factors''-has been shown to reset mouse and human somatic cell programs to a pluripotent embryonic stem cell (ESC)-like state Park et al., 2008; Takahashi et al., 2007; Takahashi and Yamanaka, 2006; Wernig et al., 2007; Yu et al., 2007) . However, we have recently found that Oct4 alone is both necessary and sufficient to reprogram neural stem cells (Kim et al., 2009b (Kim et al., , 2009c .
Transcription factor-mediated reprogramming is achieved through stochastic events, resulting in very low reprogramming efficiency (Yamanaka, 2009) . To address the heterogeneity in reprogramming factor expression, a secondary reprogramming system with consistent factor expression was developed, increasing reprogramming efficiency to $4.5% . In contrast with somatic cell nuclear transfer, $45%-50% of somatic cell nuclei consistently undergo reprogramming in $3.5 days . Four factor-mediated generation of induced pluripotent stem (iPS) cells can be achieved in $2-3 weeks, whereas protein transduction-mediated iPS cell generation takes $10-12 weeks (Kim et al., 2009a; Zhou et al., 2009) . Fusion of somatic cells with pluripotent cells is the fastest and most efficient method, with reprogrammed cells observed within 1 day . These data suggest that there may be additional or alternate reprogramming factors that can reduce the duration of reprogramming and thus improve reprogramming efficiency.
In this study, we developed a combined functional and quantitative proteomics screen to identify proteins and complexes that contribute to reprogramming. The SWI/SNF complex, found to be enriched in reprogramming-competent fractions of cell extracts from pluripotent cells, significantly increased the efficiency of four factor-mediated reprogramming. BAF complex overexpression can replace c-Myc and lead to reprogrammed cells that exhibit pluripotency and in vivo developmental potential equivalent to that of ESCs. A mechanistic insight into BAF complex function reveals that BAF complex components achieve a euchromatic chromatin state and enhance binding of reprogramming factors onto key pluripotency gene promoters, thereby enhancing reprogramming.
RESULTS

Screening Assay for Identification of Reprogramming Factors
To identify reprogramming factors, we established an assay to screen proteins from various fractions of pluripotent cell extracts. We tested the digitonin- (Hansis et al., 2004) and streptolysin 'O'-based (Taranger et al., 2005) methods to permeabilize cells and used primary mouse embryonic fibroblasts (MEFs) as the somatic cell source. Digitonin gave good induction of pluripotency genes (Figure S1A available online), with Gfp transcripts ( Figure S1B ) also detected, indicating reactivation of the Oct4 transgene in OG2MEFs (Pesce et al., 1998) ; however, no viable cells were obtained. The streptolysin 'O'-based protocol resulted in weak pluripotent gene induction (Neri et al., 2007) (Figure S1C ), with reproducibility being a concern (Miyamoto et al., 2007) . To optimize this protocol, we used adherent cells pretreated with Ca 2+ -free medium.
Primary MEFs were treated with whole-cell extracts (WCEs) from four different pluripotent cells: F9 embryonic carcinoma cells, D3 mouse ESCs, Nulli cells, a mutated cell line obtained from F9 cells, and NIH 3T3 cells. Oct4 expression was significantly increased in MEFs after treatment with extract from D3 ESCs and also detected after treatment with F9 or Nulli cell WCE. Expression of Rex1, but not that of other pluripotencyrelated genes, Sox2, Klf4, c-Myc, and Nanog, was significantly increased in MEFs after treatment with pluripotent cell extracts ( Figure 1B ), although the treated MEFs retained a fibroblast morphology. To rule out that Oct4 transcripts had originated from the pluripotent cell extracts, rather than being re-expressed by MEFs, and to determine if Oct4 activation was transient or stable, MEFs treated with F9 WCE were cultured for about 2 weeks and Oct4 expression examined. Oct4 expression increased from days 1 to 4 post-treatment and was maintained until at least day 11, indicating that it was due to endogenous (de novo) transcription and that the Oct4 promoter undergoes stable activation upon treatment with cell extract ( Figure 1C ). To rule out any RNA contamination from the extracts, WCEs were also treated with benzonase, a nuclease that digests DNA and RNA. Benzonase treatment did not interfere with Oct4 expression in MEFs; rather, it reduced the amount of streptolysin 'O' required to induce Oct4 expression ( Figure 1D ). U n t r e a t e d Untreated (D) MEFs were treated with F9 WCE or F9 WCE treated with benzonase, and cells were then treated with increasing amounts (50, 100, 200, 400, 800, and 1000 ng/ ml) of streptolysin 'O' (SLO) and Oct4 expression was analyzed. b-actin was used as a loading control. See also Figure S1 .
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Identification of BAF Complex
Components from Reprogramming-Competent F9 Fraction F9 pluripotent cell extracts were fractionated to enrich any proteins that play a role in reprogramming. WCE from F9 ESC produced similar reactivation of Oct4 expression in MEFs as WCEs from other pluripotent cells ( Figure 1B ). F9 proteins were fractionated into nuclear and cytoplasmic fractions and F9 nuclear extracts (NEs) were further separated using Q-sepharose FF chromatography ( Figure 2A and Figure S2B ). The NEs were still capable of reactivating Oct4 expression, indicating that they retained the factors required for Oct4 expression, consistent with a published study demonstrating that reprogramming factors exist in the nucleus (Do and Schö ler, 2004) and that the nuclear extraction procedure did not affect the activity of reprogramming factors. Furthermore, Fraction 1 (F1) of the NE was capable of reactivating Oct4 expression in MEFs, whereas Fraction 2 (F2) and Fraction 3 (F3) were not ( Figure S2A ). Oct4 activation was slightly increased by F1 compared with the complete NE, showing partial enrichment of reprogramming factors ( Figure 2B ). Western blot analysis using various fractions was carried out to determine the distribution of the transcription Figure S2 and Tables S1 and S2. factors involved in reprogramming. Oct4, Sox2, and Klf4 could only be detected in F1 ( Figure 2C ). Treatment of MEFs with F1 led to reactivation of endogenous Oct4 expression in just 18 hr, whereas retrovirus-mediated three-factor overexpression led to induction of endogenous Oct4 expression in $3 weeks. The presence of the reprogramming factors and the completion of Oct4 reactivation within 1 day indicate that F1 contains all factors required for efficient reprogramming. As F1 contained thousands of proteins ( Figure S2B , and see below), additional methods were established to identify pluripotent cellspecific reprogramming factors.
Mass spectrometry (MS)-based proteomics was used with an unrelated reprogramming-incompetent cell line to stringently select for alternate reprogramming factors. Using SILAC, the lysine residues of proteins in NIH 3T3 cells were labeled, increasing the molecular weight of each lysine by 8 Da (Mann, 2006; Ong et al., 2002) . Mean labeling efficiency of NIH 3T3 cells was 97% after five passages ( Figure S2C ). MaxQuant algorithms, which also calculated the exact heavy/light isotope (H/L) ratio of each protein ) identified nearly 5,000 different proteins from mixed F1 fractions of F9 NE and NIH 3T3 NE. Pluripotent cell-enriched proteins were identified by a lower H/L ratio ( Figure 2D ). Specific factors, including Oct4, Sall4, Rif1, Esrrb, and Lin28 ( Figure 2F and Table S1 ), were labeled as extreme cases and served as positive controls.
Gene ontology enrichment analysis was performed to determine the enrichment of pluripotency-associated factors based on H/L ratio (Experimental Procedures). Chromatin remodeling terms ranked top of significantly enriched ''cellular component'' terms, with the highest enriched term belonging to SWI/SNF complex proteins ( Figure 2E and Table S2 ). All subunits were several-fold overrepresented in the reprogramming-competent fraction compared with the unrelated cell extract ( Figure 2F ). Smarcc2/Baf170, the only exception, showed enrichment in the NIH 3T3 fraction, consistent with its somatic cell-specific expression (Ho et al., 2009b) .
Smarca4/Brg1, an ATPase subunit of the SWI/SNF chromatinremodeling complex (Wang, 2003) , was detected at 7-fold higher ratio in the reprogramming-competent fraction. Smarcd1/ Baf60a, Arid1a/Baf250a, Arid1b/Baf250b, and Smarcc1/Baf155 components were also highly enriched and have recently been shown to bind together and form esBAF complex (Gao et al., 2008; Ho et al., 2009b; Yan et al., 2008) .
Pluripotent Cell-Specific BAF Complex Enhances Four
Factor-Mediated Reprogramming of Somatic Cells Smarca4/Brg1, Smarcb1/Ini1, Smarcc1/Baf155, and Smarcc2/ Baf170 subunits are sufficient to constitute SWI/SNF complex activity (Phelan et al., 1999) . Ini1 and Baf170 are present at a significant level in NIH 3T3 ( Figure 2F ); only Brg1 and Baf155 were transduced in combination with Oct4, Sox2, Klf4, and cMyc (OSKM). Thus, 50,000 OG2MEFs were transduced with either the OSKM retroviruses or with the OSKM retroviruses plus those for Brg1 and Baf155 (OSKMBB). Overexpression of Brg1 and Baf155 resulted in about a 4-fold increase in GFP+ colonies on day 12. Fluorescence-activated cell sorting (FACS) showed that OSKM-and OSKMBB-mediated reprogramming resulted in 0.8% and 4.5% GFP+ cells, respectively ( Figure 3B ). GFP+ colonies produced by OSKMBB were more homogeneous and more compact than those produced by OSKM ( Figure 3A ). Therefore, we conclude that overexpression of Brg1 and Baf155 significantly enhances OSKM-mediated reprogramming.
Reprogramming mediated by the four factors passes through an intermediate stage marked by SSEA1+ GFPÀ cells (Brambrink et al., 2008) , hence cells were FACS analyzed to determine the stage at which Brg1 and Baf155 act to enhance reprogramming. When Brg1 and Baf155 were added to the four factors, there was an $1.5-fold increase (13.5% to 21.9%) in the number of SSEA1+ cells and an $5-fold increase (0.5% to 2.5%) in the number of SSEA1+ GFP+ cells ( Figure 3D ). Thus, Brg1 and Baf155 are likely to play a role at this intermediate stage of reprogramming.
Oct4, Nanog, and Rex1 Promoters Are Demethylated Faster in Brg1-and Baf155-Mediated Reprogramming Epigenetic modification of promoters of pluripotency genes in GFP+ cells obtained by either OSKM or OSKMBB was assessed to confirm the reprogramming of endogenous genes. GFP+ cells were FACS sorted at passage 0 (P0), i.e., immediately after the appearance of GFP+ colonies. The Oct4, Nanog, Rex1, and Fbx15 promoters of OSKM-mediated reprogrammed cells were 57%, 58%, 63%, and 30% methylated, respectively, whereas those of OSKMBB-mediated reprogrammed cells were 18%, 16%, 38%, and 29% methylated, respectively ( Figure 4A ). After further passage of GFP+ cells, the Oct4, Nanog, Fbx15, and Rex1 promoters in both types of reprogrammed cells were demethylated ( Figure 4B ), demonstrating that the cells had undergone complete reprogramming. Thus, Oct4, Nanog, and Rex1 promoters undergo faster demethylation in cells reprogrammed using Brg1 and Baf155 in combination with the four factors compared with those reprogrammed using only the four factors.
To assess whether faster demethylation in OSKMBB-mediated reprogramming is due to changes in the cell cycle, OG2MEFs infected with either OSKM or OSKMBB retroviruses were compared 5 days after infection. 17.3% of OSKM retrovirus-infected cells and 19.4% of OSKMBB retrovirus-infected cells were in the S phase ( Figure 4C) , showing no significant cell cycle changes.
OSKMBB-iPS Cells Have Gene Expression Profile Similar to that of ESCs
RT-PCR analysis showed OSKMBB-iPS cells expressed pluripotency-related genes, including Oct4, Sox2, Nanog, Fgf4, and Baf155, at levels comparable to those of ESCs ( Figure 5A ). Retroviral silencing of OSKMBB-iPS cells ( Figure 5B ) and genomic integration of reprogramming factors was confirmed ( Figure 5C ). Global gene expression profiles of OG2MEF, OG2ES, OSKMiPS, and OSKMBB-iPS cells, as assessed by pairwise scatter plot of DNA microarray data, demonstrated high similarity between OSKM-iPS cells, OSKMBB-iPS cells, and ESCs ( Figures  5D-5F ). Heat map and hierarchical clustering confirmed the similarity of OSKMBB-iPS cells and ESCs ( Figures 5G and 5H ).
Differentiation and Developmental Potential of OSKMBB-iPS Cells Reveals Similarity to ESCs
The differentiation potential of OSKMBB-iPS cells was assessed by embryoid body (EB) and teratoma formation. EBs cultured in the presence of retinoic acid for 5 days contained cells positive for ectodermal (Tuj1), endodermal (a-Fetoprotein), and mesodermal (T/Brachyury) markers ( Figure 6A ) and could also be differentiated into beating cardiomyocytes (Movie S1). Subcutaneous injection of OSKMBB-iPS cells into nude mice resulted in teratomas with tissues of all germ derivatives, including skin epithelium (ectoderm), muscle (mesoderm), and cuboidal epithelium (endoderm) ( Figure 6B ). These tests show that OSKMBB-iPS cells are capable of differentiating into derivatives of all three germ layers.
To assess their developmental potential, OSKMBB-iPS cells were aggregated with eight-cell embryos. Upon culture in vitro, these OSKMBB-iPS cells contributed to the inner cell mass of the developing blastocyst ( Figure 6C) , and, after transfer of the aggregated blastocysts into pseudopregnant mice, they contributed to the germline, as detected in day 13.5 embryos ( Figure 6D ). Furthermore, these aggregated blastocysts produced animals with high coat color chimerism ( Figure 6E ). To assess whether the OSKMBB-iPS cells have the capacity for germline transmission, the chimeras were mated with CD-1 female mice. Three of five pups had an Oct4-GFP allele of the donor cells, as judged by GFP expression in ovaries or testes of the pups ( Figure 6F ). These findings indicate that OSKMBBiPS cells can contribute to the full-term development of chimeras, resulting in the first generation (F1) of viable pups, and thus suggest that OSKMBB-iPS cells have a developmental capacity similar to that of ESCs.
Brg1 and Baf155 Synergistically Increase Efficiency of OSK-Mediated Reprogramming
To test whether Brg1 or Baf155 could enhance the efficiency of reprogramming mediated by Oct4, Sox2, and Klf4-i.e., in absence of c-Myc-OG2MEFs were transduced with different combinations of retroviruses (OSK retroviruses were always included). OSK-Brg1 resulted in significantly more GFP+ colonies compared with OSK, but OSK-Baf155 resulted in approximately five times more GFP+ colonies, a difference maintained until day 21 after infection ( Figure 7A ). OSK-Brg1-Baf155 resulted in 12 times more GFP+ colonies than OSK. Thus, Brg1 and Baf155 acted to synergistically enhance reprogramming efficiency in the absence of c-Myc.
Brg1 Plus Baf155 Achieves Euchromatin and Enhances Binding of Oct4
We next compared the histone methylation patterns during reprogramming mediated by OSK (3F) or OSK-Brg1-Baf155 (5F). ( Figure 7D ). The repression mark H3K27me3 was not significantly enriched on the above gene promoters (data not shown), but it was significantly reduced on the pluripotency-specific gene Sall4 promoter ( Figure 7E 
DISCUSSION
To our knowledge, this is the first study showing that a specific chromatin-remodeling complex plays a role in the generation of iPS cells through somatic cell reprogramming. Along with its bona fide function in rearranging nucleosomes, the SWI/SNF complex regulates gene expression through interactions with repressors, including Dnmt3a/3b, Mbd3, and MeCP2 (Datta et al., 2005; Harikrishnan et al., 2005; Ho et al., 2009b) .
We demonstrated that the BAF complex increases the reprogramming efficiency mediated by the ''four factors.'' Brg1 has been implicated in reprogramming using cell extract-based methods (Hansis et al., 2004) and its knockdown has been shown to affect Oct4 expression (Ho et al., 2009a (Ho et al., , 2009b Kidder et al., 2009) . These and other studies indicate that the BAF complex is involved in regulating pluripotency gene expression, which may enhance reprogramming efficiency. In addition, the interaction between c-Myc and Ini1, a component of the SWI/ SNF complex, is required for the transactivation function of c-Myc (Cheng et al., 1999) . Therefore, increased SWI/SNF complex levels, together with the four factors, may enhance c-Myc-mediated transactivation of various genes required for reprogramming, thus improving efficiency of iPS cell formation.
Overexpression of the BAF complex during four factor-mediated reprogramming increases the kinetics of Oct4, Nanog, and Rex1 promoter demethylation. The SWI/SNF complex has been postulated to play a role in demethylation of CD44 and E-cadherin promoters, as loss of Brg1/Brm results in hypermethylation (Banine et al., 2005) . The SWI/SNF complex may regulate DNA methylation either directly-i.e., by recruiting DNA methylases-or indirectly-i.e., by altering the expression of other proteins affecting DNA methylation. Brg1 has been shown to interact with the DNA methylation enzymes Dnmt3a in lymphosarcoma cells (Datta et al., 2005) and Dnmt3b in ESCs (Ho et al., 2009b) . Thus, Brg1 may recruit Dnmt3a/b onto promoters of pluripotency genes, including Oct4, Nanog, and Rex1, during reprogramming, thereby initiating DNA demethylation and improving reprogramming efficiency.
The BAF complex enhanced the efficiency of reprogramming mediated by Oct4, Sox2, and Klf4, which is important considering that c-Myc can activate several tumor pathways, resulting in reprogrammed cells that may be unsuitable for clinical applications. In contrast, the SWI/SNF complex has been shown to act as a tumor suppressor in various cell types (Reisman et al., 2009; Roberts and Orkin, 2004) and in the mouse (Bultman et al., 2000) .
Using ChIP analysis, enhanced Oct4 binding onto various pluripotency gene-specific promoters was found in the presence of BAF components. The cells were analyzed at an intermediate stage of reprogramming and in some cases the changes were small, which may be due to the fact that only a very small population of cells is undergoing reprogramming. As purification of partially reprogrammed cells was not feasible due to a very low cell number, we performed real-time analysis of the whole cell population, which is undergoing an intermediate stage of the reprogramming process. We were able to convincingly demonstrate that Oct4 binding onto Dppa4 promoter, for example, is enhanced in the presence of BAF components. Of the promoters tested, only Dppa4 is a target of Oct4, Sox2, and Klf4 as well as of Brg1, which may explain the several-fold increase in Oct4 binding to Dppa4. Increased Oct4 binding was shown for Oct4 and Sall4 promoters, for example, in the presence of BAF components, but no Oct4 binding was observed in the absence of BAF components. These results clearly show that Oct4 binding onto various promoters is enhanced in the presence of BAF components, thereby facilitating reprogramming. Interestingly, the BAF complex has been shown to play a role in maintaining Oct4 expression levels (Ho et al., 2009a (Ho et al., , 2009b Kidder et al., 2009) .
Most targets of the four factors have been shown to be methylated at K4 in ESCs, a pattern also observed in fibroblasts and partially reprogrammed cells (Sridharan et al., 2009 Additionally, a substantial increase in H3K9Ac histone acetylation level in the presence of Brg1 and Baf155 led us to conclude that the BAF complex can enhance reprogramming by increasing the euchromatic state during 5F-mediated reprogramming compared to 3F-mediated reprogramming. Our results show that the BAF complex, like c-Myc, facilitates reprogramming factor binding independent of histone methylation, thereby enhancing reprogramming efficiency.
In this study, we found that when Baf155 is overexpressed along with OSK, reprogramming efficiency is enhanced. It is likely that Baf155 enters the endogenous BAF complex and replaces Baf170, converting the complex to esBAF or a similar complex and thereby enhancing efficiency of pluripotency cellspecific functions mediated by chromatin remodeling. We also found that when Brg1 and Baf155 are overexpressed together, they increase the reprogramming efficiency in a synergistic, rather than additive, manner. This observation suggests that when both the factors are overexpressed simultaneously they form a subcomplex probably by using some of the endogenous components of the SWI/SNF complex in addition to entering endogenous BAF complexes. Thus, it appears that an increase in reprogramming efficiency due to Brg1 and Baf155 overexpression could be due to either weakening of somatic cellspecific BAF complexes or formation of small subcomplexes that support reprogramming function.
We also observed that the Brg1-containing SWI/SNF complex acts at an intermediate stage of reprogramming. The identification of additional reprogramming factors, which can either affect the four factor-mediated reprogramming or independently reprogram cells more efficiently, should help elucidate the underlying mechanisms regulating the reprogramming process and enable us to harness our resources to reprogram cells in a very efficient and highly regulated manner.
EXPERIMENTAL PROCEDURES
Cell Culture F9, Nulli-SCC1, NIH 3T3, and Plat-E (Morita et al., 2000) cells were maintained in high-glucose DMEM (PAA) containing 10%FBS, 13 penicillin/streptomycin/ glutamine (PSG) (PAA). F9 cells were maintained on gelatin-coated plates; Nulli-SCC1 cells were maintained in suspension. For maintaining Plat-E cells, 1 mg/ml of puromycin (Sigma), and 100 mg/ml of blasticidin S was added into the culture medium. ESCs were maintained in knockout DMEM containing 15% knockout serum replacement (Invitrogen), 5%FBS, 13 PSG, 13 nonessential amino acids (NEAA) (PAA), and 13 b-mercaptoethanol (Invitrogen) with were maintained on feeder layers of mitomycin C-treated MEF cells as previously described and passaged every 3 days. MEFs were isolated as described previously (Takahashi and Yamanaka, 2006) and maintained in low-glucose DMEM containing 10% FBS (Biowest), 13 PSG, 13 NEAA, and 13 b-mercaptoethanol. In this study, we used MEFs within genes in ordinate samples compared with abscissa samples are shown in blue; those downregulated are shown in red. Positions of pluripotent genes (Pou5f1/ Oct4, Sox2, Nanog, Klf4, and Lin28) are shown as green dots. Gene expression levels are in log 2 scale. five passages to avoid replicative senescence, as suggested by previous studies (Takahashi and Yamanaka, 2006) .
Cell Permeabilization and Extract Treatment
One hundred thousand MEFs were plated per well of a gelatincoated 96 well plate. Cells were washed once with Ca -free DMEM. 75 ml of extracts (equivalent to about 1300 mg WCE, 380 mg NE, and 150 mg fraction protein) supplemented with 9 ml of ATP generating system (Taranger et al., 2005) were added onto the permeabilized cells for 1 hr at 37 C. After incubation, high-glucose DMEM containing 10% FBS, 13 PSG, and 2 mM CaCl 2 was added for 2 hr. Cells were then washed twice with prewarmed knockout DMEM and cultured for another 18 hr in complete ESC medium or at other time points as stated with respective experiments, after which RNA was extracted and analyzed by quantitative PCR or semiquantitative PCR using 35 cycles of PCR.
Extract Preparation and Fractionation
Whole-cell extracts from F9 cells, ESCs, and Nulli cells were prepared as described previously (Taranger et al., 2005) . Extracts were filtered through HPF Millex-HV (Millipore) filters containing glass fibers and 0.45 mm durapore membrane and then through 0.45 mm Millex-HV filters (Millipore). Nuclear extracts were prepared as described previously (Dignam et al., 1983 ) with minor modifications. Briefly, cells were collected by trypsinization, washed twice in ice-cold PBS, washed once in swelling buffer (10 mM KCl, 10 mM HEPES [pH 7.9], 1.5 mM MgCl 2 , 2 mM DTT, 0.5 mM PMSF) and resuspended in swelling buffer for an additional 30 min on ice. Nuclei were isolated using a dounce homogenizer and their purity was verified by microscopy. Nuclei were washed once in swelling buffer and incubated in nuclear extraction buffer (420 mM KCl, 20 mM HEPES [pH 7.9], 1.5 mM MgCl 2 , 0.5 mM EDTA, 25% glycerol, 2 mM DTT, 0.5 mM PMSF) for 1 hr at 4 C. Nuclear extracts were fractionated using Q-sepharose FF chromatography and desalted using Micro Biospin chromatography columns (BioRad) before being used for screening.
SILAC Labeling and Data Analysis
NIH 3T3 cells were SILAC labeled essentially as described previously (Graumann et al., 2008) , solely using lysine ( 13 C 6 , 15 N 2 ). Fractions obtained from the F9 nuclear extract and heavy-labeled NIH 3T3 nuclear extract were mixed together at a ratio of 1:1 by protein concentration and subjected to insolution digestion with Lys-C. After separation into 12 fractions by in-solution isoelectric focusing with the Agilent OFFGEL 3100 separator, fractions were analyzed by LC-MS/MS using an easy-nLC (Proxeon) coupled to an Orbitrap (ThermoFisher Scientific). Recorded data were analyzed with MaxQuant (Cox and Mann, 2008) (version 1.0.12.19) , using the IPI mouse database (v. 3.51), allowing for two missed cleavages, requiring a minimum of six amino acids per peptide, and filtering results to a false discovery rate of 1% on the peptide and protein levels. In brief, SILAC ratios are derived from volume comparison of isotope clusters reconstructed in three dimensions (m/z, intensity, and elution time) from recalibrated high-resolution mass spectra. After identification via the MASCOT search algorithm, candidate peptide sequences are filtered for mass precision as well as the SILAC state observed with respect to the precursor ion. Resulting peptide sequences are assembled to proteins and the associated ratios averaged to a protein ratio. Plotting and downstream data analyses were performed using the R language.
Gene Ontology Enrichment Analysis
The significance of the gene ontology terms of the different expressed proteins was analyzed using an enrichment approach based on the hypergeometric distribution. To build the background set of genes, we used a set of 5111 genes detected using SILAC in ESCs (Graumann et al., 2008) . We sorted the list of proteins in the enriched fraction from the lowest to highest H/L ratio and filtered up the cases with H/L ratio lower than 0.2. Such a list was used to perform ontology enrichment analysis, based on the terms of AMIGO gene ontology (Ashburner et al., 2000) with respect to the aforementioned ESC background. The gene ontology terms were back propagated from the final term appearing in the gene annotation until the root term of each ontology. The significance (p value) of the gene ontology terms enrichment was calculated using the hypergeometric distribution and the multitest influence was corrected through controlling the false discovery rate using the Benjamini and Hochberg correction at a significance level of a = 0.05.
Retroviral Infection
The day before transfection, PLAT-E cells were seeded at a density of 5 3 10 5 cells per 60 mm dish. On the next day, pMXs-based retroviral vectors were introduced into PLAT-E cells using Fugene 6 transfection reagent (Roche), according to the manufacturer's recommendations. 9 ml of Fugene 6 transfection reagent was diluted in 200 ml of DMEM and incubated for 5 min at room temperature (RT). 3 mg of plasmid DNA was added to the mixture, which was then incubated for 15 min at RT. After incubation, the DNA/Fugene 6 mixture was added drop by drop onto the PLAT-E cells. Cells were then incubated overnight at 37 C with 5% CO 2 . 24 hr after transfection, the medium was replaced with 3 ml of fresh medium, and after another 24 hr, virus-containing supernatant was collected. Virus-containing supernatants derived from these PLAT-E cultures were filtered through 0.45 mm Millex-HV (Millipore) filters and supplemented with 6 mg/ml of protamine sulfate (Sigma). MEFs were seeded at a density of 5 3 10 4 cells per well of a 6-well plate in the presence of c-Myc, in the case of infection, or at a density of 1 3 10 5 cells per well of a 6-well plate in the absence of c-Myc on a gelatin-coated plate. Virus-containing supernatant was added onto the OG2MEF cells. Supernatant obtained from empty vector transfection was used to normalize the viral supernatant in different infections. 18 hr later, virus-containing supernatant was removed and cells were washed twice with PBS. Infected cells were maintained in culture for 5 days in highglucose DMEM containing 10% FBS and 13 PSG, with medium change after the third day. Five days later, the medium was replaced with ESC medium without c-Myc in the case of infection, whereas cells in the presence of c-Myc were passaged and plated on a 6 cm plate before being replated on 10 cm plate on day 9 in ESC medium. Cells were maintained in culture until the appearance of GFP+ colonies. Oct4 GFP+ colonies were mechanically isolated and individual cells were dissociated and subsequently replated onto mitomycin C-treated MEFs.
Plasmid Construction
Plasmids containing the cDNA of Brg1 and Baf155 were purchased (Open Biosystem). Brg1 and Baf155 were cloned into the retroviral vector pMX by using NotI and EcoRI restriction sites. The clones pMXBrg1 and pMXBaf155 were verified by sequencing.
Teratoma Formation and Histological Analysis iPS cells were suspended at a concentration of 1 3 10 7 cells/ml in DMEM containing 10% FBS. 100 ml of the cell suspension (1 3 10 6 cells) was injected subcutaneously into the dorsal flanks of nude mice. Four weeks after the injection, tumors were surgically dissected from the mice. Samples were fixed in PBS containing 4% formaldehyde and embedded in paraffin. Sections were stained with hematoxylin and eosin.
Bisulfite Genomic Sequencing Genomic DNA was isolated as per the manufacturer's instructions (Roche). Bisulfite sequencing method was based on our previously published protocol . PCR primers are listed in the Extended Experimental Procedures.
Genotype Determination
Genotyping was performed on genomic DNA isolated from iPS cells as per the manufacturer's instructions (Roche). The genotype was determined using TaqMan-based real-time PCR. Primers used for the detection of transgene expression were also used for genotype determination.
Western Blot Analyses
Western blot was performed as previously described . Primary antibodies used were anti-Oct3/4 mouse monoclonal antibody (sc-5279, Santa Cruz), anti-Sox2 rabbit polyclonal antibody (ab 59776, Abcam), antiKlf4 goat polyclonal antibody (AF 3158, R&D), and anti-Brg1 mouse monoclonal antibody (sc-17796, Santa Cruz).
PCR and Real-Time PCR for Marker Gene and Transgene Expression
Total RNA was extracted from cells using the RNeasy Micro Kit (QIAGEN GmbH) according to the manufacturer's instructions. cDNA synthesis was performed with the High Capacity cDNA Archive Kit (Applied Biosystems GmbH) following the manufacturer's instructions with a down-scaled reaction volume of 20 ml. Transcript levels were determined using the ABI PRISM 7900 Sequence Detection System (Applied Biosystems) and the ready-to-use 5 0 -nuclease Assays-on-Demand. For real-time amplification, the template was equivalent to 5 ng of total RNA. Quantification was normalized to the endogenous Hprt1 gene within the log-linear phase of the amplification curve obtained for each probe/primer set using the DDCt method (ABI PRISM 7700 Sequence Detection System, user bulletin number 2); Hprt1 was used as an internal standard. Oligonucleotides were designed by the TaqMan Assays-on-Demand. Assay numbers are listed in Table S2 . Primer sequences for viral-specific Oct4, Sox2, Klf4, and c-Myc are as previously described ; 35 cycles of semiquantitative PCR was carried out for the analysis for Oct4 and b-actin. PCR primers are listed in the Extended Experimental Procedures.
Whole Genome Expression Analysis RNA samples to be analyzed on microarrays were prepared using QIAGEN RNeasy columns with on-column DNA digestion. 400 ng of total RNA per sample was used as input into a linear amplification protocol (Ambion), which involved synthesis of T7-linked double-stranded cDNA and 12 hr of in vitro transcription incorporating biotin-labeled nucleotides. Purified and labeled cRNA was then hybridized for 18 hr onto MouseWG-6 v2 expression BeadChips (Illumina) following the manufacturer's instructions. After washing, as recommended, chips were stained with streptavidin-Cy3 (GE Healthcare) and scanned using the iScan reader (Illumina) and accompanying software. Samples were exclusively hybridized as biological replicates.
Microarray Data Processing
For microarray data processing, the following was done: bead intensities were mapped to gene information using BeadStudio 3.2 (Illumina); background correction was performed using the Affymetrix Robust Multi-array Analysis background correction model; variance stabilization was performed using log 2 scaling; and gene expression normalization was calculated with the quantile method implemented in the lumi package of R-Bioconductor. Data postprocessing and graphics were performed with in-house developed functions in MATLAB. Hierarchical clusters of genes and samples were performed with a one minus correlation metric and the average (unweighted pair group) linkage method.
In Vitro Differentiation of iPS Cells
Cells were harvested by trypsinization and transferred to bacterial culture dishes in ESC medium without leukemia inhibitory factor. After 3 days in culture, aggregated cells were plated onto gelatin-coated tissue culture dishes and incubated for 5 days in the presence of 5 mM retinoic acid. Cells were stained with anti-Tuj1 monoclonal antibody (Covance), anti-Sox17 antibody (R&D Systems), or anti-Brachyury (Santa Cruz Biotechnology, Inc.) antibody and counterstained with DAPI (Vector).
Chimera Formation
Chimera formation and germline transmission were carried out as described previously . Briefly, iPS cells were aggregated and cultured with denuded post-compacted eight-cell stage mouse embryos. After 24 hr in culture, most aggregates had formed blastocysts. Aggregated blastocysts were then transferred into the uterine horns of pseudopregnant mice.
Chromatin Immunoprecipitation Assay
ChIP was performed using the low cell number ChIP kit (Diagenode) according to the manufacturer's recommendations with minor modifications as follows. Cells were collected by trypsinization, washed twice in PBS, crosslinked for 45 min at RT in disuccinimidyl glutarate (DSG; Pierce cat. no. 20593), and then washed thrice in PBS and crosslinked in 1% formaldehyde for 8 min at RT. Antibodies used in this experiment were anti-Oct3/4 goat polyclonal antibody (N-19; Santa Cruz) and goat polyclonal antibody (Santa Cruz). Primers used for the ChIP analysis have been described in the Extended Experimental Procedures.
ACCESSION NUMBERS
The microarray data discussed have been deposited in NCBI's Gene Expression Omnibus (Edgar et al., 2002) with accession number GSE18330 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE18330).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, two figures, five tables, and one movie and can be found with this article online at doi:10.1016/j.cell.2010.04.037.
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